Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion type Assertion NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_head.
- NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion description "[Targeted proteins, associated with different signal transduction pathways, have included transforming growth factor-alpha [TGF-alpha (MR(1))], its binding site the epidermal growth factor receptor [EGFR (MR(2))] sharing sequence homology to the breast cancer prognostic marker Her-2/neu, an apoptosis inhibiting protein [bcl-2 (MR(4))], and the androgen receptor [AR (MR(5))].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_provenance.
- NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion evidence source_evidence_literature NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_provenance.
- NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion SIO_000772 18686047 NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_provenance.
- NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion wasDerivedFrom befree-2016 NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_provenance.
- NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_assertion wasGeneratedBy ECO_0000203 NP686587.RA8S3B94MO4DYJX_qynh0jHM-G5KhvVRDXoqcVC0QDHJ4130_provenance.